Interpreting diagnosis outcomes for tuberculosis to timely and reliably predict non-tuberculosis mycobacteria isolation
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Biyi Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, PR China. Hauptthemen laut MEDLINE: Nontuberculous Mycobacteria, Mycobacterium Infections, Nontuberculous, Tuberculosis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Fund of China, the Science and Technology Program of Guangzhou, The National Key Research and Development Program of China.
Abstract (Originalsprache)
Introduction
Timely distinguishing non-tuberculous mycobacteria (NTM) from Mycobacterium tuberculosis is needed, but it is challenging. Hypothesis. Smear-positive and tuberculosis (TB) molecular-test-negative outcomes could timely and accurately predict NTM existence in the clinical specimen. Methodology. Laboratory outcomes of the smear test and TB molecular test outcomes were evaluated in a high TB and NTM prevalence setting. Additionally, the interferon-gamma release assay (IGRA) outcome was scrutinized to assess its supplementary value to the above strategy.
Results
The smear-positive/Xpert MTB/RIF (Cepheid, USA) outcomes accurately predicted 91.67% (198/216) of the NTM isolation, while that of smear-positive/Simultaneous Amplification and Testing method (SAT-TB) (Rendu Biotechnology, China) negative outcomes was 84.5% (169/200). Applying these indicators to rule out TB could achieve an accuracy of up to 99.49% (3435/3453). Combining smear-positive, Xpert-negative and SAT-TB-negative outcomes increased the accuracy up to 95%. Adding a negative IGRA outcome to the indicators further increased the accuracy to over 96%, albeit at the cost of losing prediction sensitivity. When evaluating the strategy in NTM isolates, the indicators successfully predicted about 40% of these isolations with over 92% accuracy.
Conclusion
A smear-positive/molecular TB test-negative outcome could timely and accurately predict NTM isolation in the given setting. This strategy could predict ~40% of the NTM isolations of the patients on their first day of hospital visit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Laboratory, Guangzhou Chest Hospital, Guangzhou, PR China.
- National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beiji…
Förderung
- the Natural Science Fund of China
- the Science and Technology Program of Guangzhou
- The National Key Research and Development Program of China
- the Beijing Public Health Experts Project
Zitieren
APA
Su, B., Qi, H., Tan, Y., & Huang, H. (2025). Interpreting diagnosis outcomes for tuberculosis to timely and reliably predict non-tuberculosis mycobacteria isolation. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002009
Vancouver
Su B, Qi H, Tan Y, Huang H. Interpreting diagnosis outcomes for tuberculosis to timely and reliably predict non-tuberculosis mycobacteria isolation. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002009
BibTeX
@article{Su2025,
author = {Su, Biyi and Qi, Haoran and Tan, Yaoju and Huang, Hairong},
title = {Interpreting diagnosis outcomes for tuberculosis to timely and reliably predict non-tuberculosis mycobacteria isolation},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002009}
}
EUVIMED